Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04732962 · ClinicalTrials.gov registry record · NA

Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement

A NA study of Osteoarthritis, Knee, sponsored by Geisinger Clinic.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
2
Study locations

NCT04732962: Recruiting NA study of Osteoarthritis, Knee, sponsored by Geisinger Clinic.

NCT04732962 is a NA study of Osteoarthritis, Knee that is actively recruiting participants, run by Geisinger Clinic. The registered enrollment target is 150 participants, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (70% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04732962, a NA study of Osteoarthritis, Knee, is actively recruiting participants, sponsored by Geisinger Clinic.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
2
Study locations

Study Summary

Osteoarthritis (OA), the most common type of arthritis, affects more than 32.5 million adults in the United States. It is also among the most expensive condition to treat when joint replacement surgery is required. Although biomechanics plays an important role in OA disease, the non-surgical treatment options addressing biomechanics are scarce with limited effect. AposHealth is the fist biomechanical treatment that was shown to have a significant short-term effect on patients with knee OA. The main objectives of this study are: 1. To assess AposHealth, a non-invasive home-based biomechanical treatment, as an alternative treatment for patients who are eligible for Total Knee Replacement (TKR). 2. To assess AposHealth as a new post-operative rehabilitation tool for patients post TKR.

Primary Outcome

score range: worst 0 - 10 best

Conditions Studied

Interventions

  • DEVICE AposHealth
  • PROCEDURE Total Knee Replacement (TKR)

Study Locations (2)

Pennsylvania

  • Geisinger Medical Center - Danville
  • Geisinger - Orthopaedics Wilkes-Barre - Wilkes-Barre

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2021-07-22
Est. Completion 2026-03
Phase NA
Geisinger Clinic

107 total trials

What NCT04732962 shows while recruiting

NCT04732962 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 496-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 2 interventions - of which AposHealth is the first listed.

NCT04732962 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04732962 about?

NCT04732962 is a clinical study titled "Biomechanical Footwear as a Non-invasive Alternative and Supplement to Total Knee Replacement". Osteoarthritis (OA), the most common type of arthritis, affects more than 32.5 million adults in the United States. It is also among the most expensive condition to treat when joint replacement surgery is required. Although biomechanics plays an important role in OA disease, the non-surgical treatme...

What is the current status of trial NCT04732962?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2021-07-22. Estimated completion is 2026-03.

What conditions does trial NCT04732962 study?

This clinical trial studies the following conditions: Osteoarthritis, Knee.

What interventions are being tested in trial NCT04732962?

The interventions under investigation include: AposHealth (DEVICE), Total Knee Replacement (TKR) (PROCEDURE).

Who is sponsoring clinical trial NCT04732962?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04732962 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis, Knee

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04732962's enrollment target sits among peer trials

150 43rd of 112 higher than 66 of 112 other Osteoarthritis, Knee trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04732962, the US trial registry maintained by the National Library of Medicine. NCT04732962 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.